Treatment of depression in adults with cancer: a systematic review of randomized controlled trials
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: Depression is a leading cause of disease burden worldwide and is especially problematic in people with chronic diseases, including cancer. Although depression can be effectively treated in the general population using antidepressant medication and psychological treatments, these treatments may have different benefits and harms in cancer patients. Previous reviews have not adequately addressed this topic. We therefore aimed to determine which, if any, treatments are effective for patients with diagnoses of both cancer and depression. Method: We conducted a systematic review of relevant randomized controlled trials identified through searches of Medline, EMBASE, PsycINFO and The Cochrane Central Register of Controlled Trials (CENTRAL). Results: Seven relatively small trials met the selection criteria. These provided some evidence that antidepressant medication, given alone or in combination with a psychological treatment, may be effective. We found no good evidence for psychological treatments given alone or for any other forms of treatment. Conclusions: There is very limited evidence from clinical trials to guide the treatment of cancer patients with a diagnosis of depression, especially for psychological treatments. High quality trials of treatments for depression in patients with cancer are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Psychotherapy for depression among incurable cancer patients
Akechi, T., Okuyama, T., Onishi, J., Morita, T., & Furukawa, T. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005537.pub2 · Cited by 198 · cited 1×
“…ARTICLE 1999; Barsevick et al. 2002; Ly et al. 2002; Osborn et al. 2006; Williams & Dale, 2006; Rodin et al. 2007; Akechi et al. 2008; Fann et al. 2008; Jiang et al. 2010; Rooney & Grant, 2010; Gordon et al. 2011; Ng et al. 2011; Rayner et al 2011; Craft et al.…”
RetractedDepression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
Depression and cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Psychological Medicine · doi:10.1017/s0033291709992285 · Cited by 1,083 · cited 1×
“…associated with lower adherence to anticancer therapies, satisfaction with care and quality of life, and higher health-care costs and mortality (Colleoni et al. 2000; Bui et al. 2005; Brown et al 2010; Goldzweig et al. 2010; Kroenke et al. 2010a, c; Pinquart & Duberstein, 2010; Walker et al. 2013).”
BackgroundOsborn, R. L., Demoncada, A. C., & Feuerstein, M. (2006) · The International Journal of Psychiatry in Medicine · doi:10.2190/eufn-rv1k-y3tr-fk0l · Cited by 621
Major depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
Sheard, T., & Maguire, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690596 · Cited by 533
Non-communicable diseases must have greater priority, says WHO
Zarocostas, J. (2009) · BMJ · doi:10.1136/bmj.b2857 · Cited by 517
The Maudsley Prescribing Guidelines
Taylor, D., Paton, C., & Kerwin, R. (2007) · doi:10.1201/b21605 · Cited by 366
Depression and degree of acceptance of adjuvant cytotoxic drugs
Colleoni, M., Mandala, M., Peruzzotti, G., Robertson, C., Bredart, A., & Goldhirsch, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02821-x · Cited by 351
Brown, L. F., Kroenke, K., Theobald, D. E., Wu, J., & Tu, W. (2010) · Psycho-Oncology · doi:10.1002/pon.1627 · Cited by 295 · cited 1×
“…associated with lower adherence to anticancer therapies, satisfaction with care and quality of life, and higher health-care costs and mortality (Colleoni et al. 2000; Bui et al. 2005; Brown et al 2010; Goldzweig et al. 2010; Kroenke et al. 2010a, c; Pinquart & Duberstein, 2010; Walker et al. 2013).”
BackgroundExercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis
Craft, L. L., VanIterson, E. H., Helenowski, I. B., Rademaker, A. W., & Courneya, K. S. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0634 · Cited by 277 · cited 1×
“…ARTICLE 1999; Barsevick et al. 2002; Ly et al. 2002; Osborn et al. 2006; Williams & Dale, 2006; Rodin et al. 2007; Akechi et al. 2008; Fann et al. 2008; Jiang et al. 2010; Rooney & Grant, 2010; Gordon et al. 2011; Ng et al. 2011; Rayner et al 2011; Craft et al. 2012; Hart et al. 2012).”
Efficacy and safety of mianserin in the treatment of depression of women with cancer
Costa, D., Mogos, I., & Toma, T. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb08081.x · Cited by 202 · cited 1×
“Two of these compared the antidepressant drug mianserin with placebo and found statistically significant differences in depression outcomes (Costa et al. 1985; van Heeringen & Zivkov, 1996).”
ResultHopko, D. R., Armento, M. E. A., Robertson, S. M. C., Ryba, M. M., Carvalho, J. P., Colman, L. K., Mullane, C., Gawrysiak, M., Bell, J. L., McNulty, J. K., et al. (2011) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0025450 · Cited by 193
The clinical significance of quality of life assessments in oncology: a summary for clinicians
Sloan, J. A., Frost, M. H., Berzon, R., Dueck, A., Guyatt, G., Moinpour, C., Sprangers, M., Ferrans, C., Cella, D., & Clinical Significance Consensus Meeting Group (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0085-y · Cited by 149
The prevalence and pharmacotherapy of depression in cancer patients
Ng, C. G., Boks, M. P. M., Zainal, N. Z., & de Wit, N. J. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.07.034 · Cited by 138 · cited 1×
“…ARTICLE 1999; Barsevick et al. 2002; Ly et al. 2002; Osborn et al. 2006; Williams & Dale, 2006; Rodin et al. 2007; Akechi et al. 2008; Fann et al. 2008; Jiang et al. 2010; Rooney & Grant, 2010; Gordon et al. 2011; Ng et al. 2011; Rayner et al 2011; Craft et al. 2012; Hart et al. 2012).”
Uncritical positive regard? Issues in the efficacy and safety of psychotherapy
Nutt, D. J., & Sharpe, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107086283 · Cited by 123 · cited 1×
“In addition to the obvious cost implications and burden on patients from providing potentially ineffective treatments, the assumption that non-drug treatments are without risk is highly questionable (Nutt & Sharpe, 2008).”
BackgroundSelf-citationImproving Primary Care for Older Adults with Cancer and Depression
Fann, J. R., Fan, M.-Y., & Unützer, J. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0999-4 · Cited by 91
Cited by
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
“Antidepressants and, less frequently, benzodiazepines are used to treat depressed mood and anxiety in cancer patients, although evidence suggesting efficacy is limited and conflicting, and benzodiazepines are generally only recommended for short-term use because of side effects and withdrawal (Grassi et al., 2014; Ost…”
BackgroundBallesta, A., Innominato, P. F., Dallmann, R., Rand, D. A., & Lévi, F. A. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013441 · Cited by 339
Sharpe, M., Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Gourley, C., Wall, L., Weller, D., & Murray, G. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61231-9 · Cited by 269
Self-citationSwift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N., Terrana, S., Friedman, H. L., Guss, J., Bossis, A. P., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817715966 · Cited by 195
“…psychological consequences of a cancer diagnosis are far-reaching, complex, and often pervasive, with conventional pharmacotherapies showing limited efficacy to address symptoms of anxiety and depression (Grassi et al., 2014; Ostuzzi, Matcham, Dauchy, Barbui, & Hotopf, 2015; Walker et al., 2014).”
BackgroundLi, M., Kennedy, E. B., Byrne, N., Gérin-Lajoie, C., Katz, M. R., Keshavarz, H., Sellick, S., & Green, E. (2017) · Psycho-Oncology · doi:10.1002/pon.4286 · Cited by 151
Metadata
- Authors
- Walker, J., Sawhney, A., Hansen, C. H., Ahmed, S., Martin, P., Symeonides, S., Murray, G., & Sharpe, M.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2013-06-19
- Volume
- 44
- Issue
- 5
- Pages
- 897-907
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2039746812
- Cited by
- 67
- References
- 17
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.